BRPI0406859A - Composições farmacêuticas em pó - Google Patents
Composições farmacêuticas em póInfo
- Publication number
- BRPI0406859A BRPI0406859A BR0406859-9A BRPI0406859A BRPI0406859A BR PI0406859 A BRPI0406859 A BR PI0406859A BR PI0406859 A BRPI0406859 A BR PI0406859A BR PI0406859 A BRPI0406859 A BR PI0406859A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- powder pharmaceutical
- powder
- powdered
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Otolaryngology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"COMPOSIçõES FARMACêUTICAS EM Pó". A presente invenção refere-se a composições farmacêuticas em pó que são solúveis em um líquido como água quente, em que as ditas composições proporcionam um efeito terapêutico no tratamento dos sintomas associados ao resfriado comum e/ou à gripe. Essas composições farmacêuticas em pó contêm um ativo farmacêutico selecionado que é especialmente eficaz no alívio dos sintomas de resfriados e/ou gripes.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/349,665 US20040162273A1 (en) | 2003-01-23 | 2003-01-23 | Powder pharmaceutical compositions |
PCT/US2004/001249 WO2004066978A1 (en) | 2003-01-23 | 2004-01-16 | Powder pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0406859A true BRPI0406859A (pt) | 2006-02-07 |
Family
ID=32823699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0406859-9A BRPI0406859A (pt) | 2003-01-23 | 2004-01-16 | Composições farmacêuticas em pó |
Country Status (10)
Country | Link |
---|---|
US (1) | US20040162273A1 (pt) |
EP (1) | EP1587498A1 (pt) |
JP (1) | JP2006515603A (pt) |
CN (1) | CN1738604A (pt) |
BR (1) | BRPI0406859A (pt) |
CA (1) | CA2509807A1 (pt) |
MX (1) | MXPA05007826A (pt) |
PL (1) | PL378011A1 (pt) |
RU (1) | RU2005123045A (pt) |
WO (1) | WO2004066978A1 (pt) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0307440D0 (en) * | 2003-03-31 | 2003-05-07 | Novartis Ag | Organic compounds |
CN101262852A (zh) * | 2004-12-13 | 2008-09-10 | 麦克内尔-Ppc股份有限公司 | 稳定活性药物成分的组合物和方法 |
US20070249727A1 (en) | 2006-04-21 | 2007-10-25 | The Proctor & Gamble Company | Compositions and kits useful for treatment of respiratory illness |
US10022339B2 (en) | 2006-04-21 | 2018-07-17 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
US20070254027A1 (en) | 2006-04-28 | 2007-11-01 | The Procter & Gamble Company | Compositions and methods useful for treatment of respiratory illness |
US20080014275A1 (en) * | 2006-07-13 | 2008-01-17 | Buehler Gail K | Pharmaceutical suspensions and related methods |
US20080268025A1 (en) * | 2007-04-25 | 2008-10-30 | Donald Spector | Compositions Useful for Preventing Pain and Soreness Resulting from Exercise and Methods of Use |
AU2008280801B2 (en) * | 2007-07-23 | 2014-03-06 | Kingsway Pharmaceuticals Inc. | Therapeutic formulations for the treatment of cold and flu-like symptoms |
WO2014120021A1 (en) * | 2013-02-04 | 2014-08-07 | Aft Pharmaceuticals Limited | A combination medicament comprising phenylephrine and paracetamol |
US20140271923A1 (en) | 2013-03-14 | 2014-09-18 | Christopher Brian Reid | Compositions & formulations for preventing and treating chronic diseases that cluster in patients such as cardiovascular disease, diabetes, obesity, polycystic ovary syndrome, hyperlipidemia and hypertension, as well as for preventing and treating other diseases and conditions |
ES2863988T3 (es) * | 2015-05-21 | 2021-10-13 | Abdi Ibrahim Ilac Sanayi Ve Ticaret A S | Formulaciones farmacéuticas con mejor solubilidad y estabilidad |
CR20200552A (es) | 2018-05-16 | 2021-05-13 | Bayer Healthcare Llc | Fórmula de suspención de alta concentración para medicamentos en cápsula de gel blanda paae resfriado y gripe |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4260600A (en) * | 1979-10-22 | 1981-04-07 | Ronald Valle | Method of treating depression |
US4552899A (en) * | 1984-04-09 | 1985-11-12 | Analgesic Associates | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
US4631284A (en) * | 1984-11-19 | 1986-12-23 | Mallinckrodt, Inc. | Acetaminophen compositions containing low doses of chlorpheniramine maleate, method for preparing same and tablets formed therefrom |
US4771077A (en) * | 1986-10-21 | 1988-09-13 | American Home Products Corporation (Del.) | Spray dried acetaminophen |
US4975426A (en) * | 1987-06-08 | 1990-12-04 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
US5814337A (en) * | 1992-10-07 | 1998-09-29 | Beecham Group Plc | Pharmaceutical formulation |
GB9224021D0 (en) * | 1992-11-16 | 1993-01-06 | Boots Co Plc | Effervescent compositions |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US6462094B1 (en) * | 2001-08-22 | 2002-10-08 | Medpointe Healthcare Inc. | Decongestant/expectorant compositions |
-
2003
- 2003-01-23 US US10/349,665 patent/US20040162273A1/en not_active Abandoned
-
2004
- 2004-01-16 MX MXPA05007826A patent/MXPA05007826A/es unknown
- 2004-01-16 CA CA002509807A patent/CA2509807A1/en not_active Abandoned
- 2004-01-16 WO PCT/US2004/001249 patent/WO2004066978A1/en not_active Application Discontinuation
- 2004-01-16 BR BR0406859-9A patent/BRPI0406859A/pt not_active IP Right Cessation
- 2004-01-16 CN CNA2004800023718A patent/CN1738604A/zh active Pending
- 2004-01-16 PL PL378011A patent/PL378011A1/pl not_active Application Discontinuation
- 2004-01-16 JP JP2005518288A patent/JP2006515603A/ja not_active Abandoned
- 2004-01-16 EP EP04703004A patent/EP1587498A1/en not_active Withdrawn
- 2004-01-16 RU RU2005123045/15A patent/RU2005123045A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2509807A1 (en) | 2004-08-12 |
PL378011A1 (pl) | 2006-02-20 |
RU2005123045A (ru) | 2006-01-27 |
MXPA05007826A (es) | 2005-10-18 |
EP1587498A1 (en) | 2005-10-26 |
US20040162273A1 (en) | 2004-08-19 |
WO2004066978A8 (en) | 2005-03-24 |
WO2004066978A1 (en) | 2004-08-12 |
CN1738604A (zh) | 2006-02-22 |
JP2006515603A (ja) | 2006-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008028965A3 (en) | Inhibitors of protein phosphatase 1, gadd34 and protein phosphatase 1/gadd34 complex, preparation and uses thereof | |
BRPI0406859A (pt) | Composições farmacêuticas em pó | |
CL2007002261A1 (es) | Compuestos derivados de imidazo[1,2-b]piridazina, inhibidores de quinasa; composicion farmaceutica; y uso en el tratamiento o prevencion del cancer. | |
CL2008001721A1 (es) | Compuestos derivados de 17-beta-ciano-18 alfa-homo-19-nor-androst-4-eno; que presentan actividad gestagena y antimineralcorticoide; composicion farmaceutica; y uso en el tratamiento de trastornos pre-peri-y posmenopausicos y trastornos premenstruales. | |
TW200716208A (en) | Modified and immediate release memantine bead formulation | |
UY28931A1 (es) | Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis | |
BRPI0611717A2 (pt) | composto, composiÇço farmacÊutica e uso do composto | |
BRPI0518255A2 (pt) | mÉtodos de tratamento ou prevenÇço de uma lesço do sistema nervoso central, para reduzir ou evitar um efeito adverso, e composiÇço farmacÊutica | |
WO2006078424A3 (en) | Polyherbal compositions and methods for treating viral infections | |
PT1181027E (pt) | Composicao dietetica ou farmaceutica para utilizacao na prevencao ou tratamento de hiperoxaluria | |
NO20092639L (no) | 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav | |
CL2007003523A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer | |
MY162640A (en) | Thioninium compounds and their use | |
ATE363896T1 (de) | Gegen missbrauch gesicherte darreichungsform | |
CL2007002953A1 (es) | Compuestos derivados de espiro-oxindol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del dolor, cancer, prurito, hiperplasia prostatica benigna, hipercolesterolemia. | |
TNSN01040A1 (fr) | Compositions nouvelles comprenant des inhibiteurs de glycogene- phosphorylase | |
CL2007002671A1 (es) | Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc. | |
CL2007003038A1 (es) | Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos. | |
MA34670B1 (fr) | Inhibiteurs de l'apoptose et leurs utilisations | |
BRPI0415753A (pt) | método para tratamento e prevenção da inflamação respiratória com um inibidor de ciclooxigenase-2 em associação com um inibidor de fosfodiesterase 4 e composições que os contêm | |
CL2006003449A1 (es) | Compuestos derivados de n-(fluoro-pirazinil)-fenilsulfonamidas; procedimiento de preparacion; compuesto intermediario; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del asma. | |
BRPI0518062A (pt) | uso de um modulador de pde4, ou um sal, solvato, ou estereoisÈmero farmaceuticamente aceitável do mesmo, e, composição farmacêutica | |
TW200738239A (en) | Stable solid formulation of sertindole | |
BR0213181A (pt) | Combinações de inibidor de cox-2 | |
EE200300064A (et) | Farmatseutiline kompositsioon C. pneumoniae pooltpõhjustatud infektsioonide raviks ja/või ennetamiseks, mahekompositsioon ja nende kasutamine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 3A , 4A , 5A , 6A , 7A E 8A ANUI DADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011. |